Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from MedAdvisor Limited ( (AU:MDR) ).
MedAdvisor Limited reported a significant financial downturn for the year ending June 30, 2025, with revenues from ordinary activities decreasing by 36% to approximately $63 million. The company experienced a substantial loss of over $60 million, a stark contrast to the previous year’s profit of $792,133, indicating severe financial challenges. No dividends were declared for the current or previous financial periods, highlighting the company’s focus on stabilizing its financial position. This downturn could impact MedAdvisor’s market positioning and stakeholder confidence, necessitating strategic adjustments to address the financial losses.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, providing digital solutions aimed at improving medication management and adherence. The company focuses on leveraging technology to enhance healthcare outcomes for patients and streamline processes for healthcare providers.
Average Trading Volume: 955,572
Technical Sentiment Signal: Sell
Current Market Cap: A$34.39M
See more data about MDR stock on TipRanks’ Stock Analysis page.